GLUCOCORTICOID-INDUCED INCREASE IN PLASMA CORTICOSTEROID-BINDING GLOBULIN LEVELS IN FETAL SHEEP IS ASSOCIATED WITH INCREASED BIOSYNTHESIS AND ALTERATIONS IN GLYCOSYLATION
Etm. Berdusco et al., GLUCOCORTICOID-INDUCED INCREASE IN PLASMA CORTICOSTEROID-BINDING GLOBULIN LEVELS IN FETAL SHEEP IS ASSOCIATED WITH INCREASED BIOSYNTHESIS AND ALTERATIONS IN GLYCOSYLATION, Endocrinology, 132(5), 1993, pp. 2001-2008
In fetal sheep, there is a concomitant prepartum rise in cortisol and
corticosteroid-binding globulin (CBG) that maintains a low free plasma
cortisol level and allows for a low negative feedback effect of corti
sol on the secretion of ACTH from the fetal pituitary. However, the st
imulus for the prepartum increase in CBG and the mechanism(s) of this
effect are not known. It has been proposed that glucocorticoids increa
se CBG concentrations, and therefore, we infused fetal sheep with the
synthetic glucocorticoid dexamethasone (DEX; 2 mug/min over 15 min eve
ry 2 h for 96 h, n = 5) or saline (n = 5). The plasma corticosteroid-b
inding capacity increased from 30.0 +/- 2.4 to 55.6 +/- 7.7 and 92.6 /- 11.1 ng/ml at 48 and 96 h, respectively, of DEX infusion. To examin
e possible mechanisms of increasing fetal plasma CBG, we first cloned
and sequenced a sheep CBG cDNA and purified the protein. This allowed
us to deduce the primary structure of ovine CBG and to demonstrate tha
t hepatic CBG mRNA abundance (single transcript of 1.8 kilobases) rose
from 0.9 +/- 0.2 to 3.6 +/- 1.6 arbitrary units after 96 h of DEX tre
atment. Fetal DEX treatment produced a significant increase (7.1 +/- 1
.2% to 13.1 +/- 1.4%) in the Concanavalin-A-binding forms of CBG that
predominate in adult sheep plasma. There was negligible transfer of pu
rified [I-125] CBG from the ewe to fetal plasma, urine, or amniotic fl
uid. We also injected adult sheep with DEX (10 mg/day for 4 days) and
demonstrated a significant decrease in plasma corticosteroid-binding c
apacity by 24 h, which remained suppressed for the duration of the stu
dy. After 96 h of DEX treatment, there was also a significant decrease
in adult hepatic CBG mRNA abundance. We conclude that glucocorticoids
increase fetal plasma CBG in part by increased hepatic biosynthesis.
It may also be accentuated by a change in the glycosylation of CBG, bu
t cannot be attributed to transplacental transfer. Furthermore, glucoc
orticoid treatment exerts opposite effects on CBG biosynthesis in feta
l and adult sheep.